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IMPORTANCE Patterns of body size and body composition associated with genetic obesity
susceptibility inform themechanisms that increase obesity risk.
OBJECTIVE To test associations between genetic obesity susceptibility, represented by a
combined obesity risk-allele score, and body size or body composition at birth to age 5 years.
DESIGN, SETTING, AND PARTICIPANTS A total of 3031 children from 4 birth cohort studies in
England, France, and Spain were included in a meta-analysis.
EXPOSURES A combined obesity risk-allele score was calculated from genotypes at 16
variants identified by genome-wide association studies of adult bodymass index (BMI).
MAIN OUTCOMES ANDMEASURES Outcomeswere age- and sex-adjusted SD scores (SDS) for
weight, length/height, BMI, fat mass, leanmass, and percentage of body fat at birth as well as
at ages 1, 2 to 3, and 4 to 5 years.
RESULTS The obesity risk-allele score was not associated with infant size at birth; at age 1 year
it was positively associated with weight (β [SE], 0.020 [0.008] SDS per allele; P = .009) and
length (β [SE], 0.020 [0.008] SDS per allele; P = .01), but not with BMI (β [SE], 0.013 [0.008]
SDS per allele; P = .11). At age 2 to 3 years these associations were stronger (weight: β [SE],
0.033 [0.008] SDS per allele; P < .001; height: β [SE], 0.025 [0.008] SDS per allele; P < .001)
and were also seen for BMI (β [SE], 0.024 [0.008] SDS per allele; P = .003). The obesity
risk-allele score was positively associated with both postnatal fat mass (1 year: β [SE],
0.032 [0.017] SDS per allele; P = .05; 2-3 years: β [SE], 0.049 [0.018] SDS per allele;
P = .006; and 4-5 years: β [SE], 0.028 [0.011] SDS per allele; P = .009) and postnatal lean
mass (1 year: β [SE], 0.038 [0.014] SDS per allele; P = .008; 2-3 years: β [SE], 0.064 [0.017]
SDS per allele; P < .001; and 4-5 years: β [SE], 0.047 [0.011] SDS per allele; P < .001), but not
with the percentage of body fat (P > .15 at all ages).
CONCLUSIONS AND RELEVANCE Genetic obesity susceptibility appears to promote a normally
partitioned increase in early postnatal, but not prenatal, growth. These findings suggest that
symmetrical rapid growthmay identify infants with high life-long susceptibility for obesity.
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I dentification of the early-life indicators and mechanismsrelated to later obesity risk has important relevance topreventive strategies.1 Consistent evidence frommany lon-
gitudinal studies2,3 supports the hypothesis that rapid postna-
tal weight gain is a risk factor for later obesity. A recent
meta-analysis3 of multiple international studies demon-
stratedthata1-unitgain inweightSDscore (SDS)during the first
yearof lifeconferreda23%higherriskofadultobesityand2-fold
higher riskof childhoodobesity. Studies3 relating infantgrowth
to later obesity have largely focused on weight or weight-for-
length measures, although there is some evidence4 that in-
creased linear growth during the first 2 years of life is also as-
sociated with a higher risk of obesity in later childhood.
There is as yet little evidence to showwhether early gains
in fatmass, fat-freemass, or both are associatedwith suscep-
tibility to later obesity.5 Body composition in infancy is infre-
quentlymeasured in epidemiologic studies and is notably ab-
sent from historical cohort studies with adult outcome
measurements.As such, the relevanceof body composition in
infancy to the programming of later obesity is poorly under-
stood. The identification6 of genetic variants with robust as-
sociationwithcomplextraitsbygenome-wideassociationstud-
ieshasallowedexaminationof theearly-lifephenotypesrelated
to genetic susceptibility to disease. Using this approach, sev-
eral studies6-8 have inferred that gains in both infancyweight
and length are positively associatedwith lifelongobesity risk,
based on associations between genetic variants that predis-
pose to higher adult body mass index (BMI) and markers of
earlypostnatal growth.However, studies todatehavebeen re-
stricted to measures of weight, length/height, and BMI and
have not examined genetic associations withmeasures of in-
fantbodycomposition.To identifypatternsof early lifegrowth
and body composition that are related to genetic obesity sus-
ceptibility,wecombineddataon thesephenotypes from4con-
temporary birth cohort studies to allow a robust examination
of their associations with an obesity susceptibility multiple-
allelic score comprising genetic variants identified in large-
scale genome-wide association studies of adult BMI.9
Methods
Study Descriptions
The 4 contemporary birth cohort studies used in the meta-
analysis were the Cambridge Baby Growth Study (CBGS), the
SouthamptonWomen’s Survey (SWS), a mother-child cohort
studyonprenatal andpostnataldeterminantsof thechild'sde-
velopment and health (EDEN), and the Barcelona study. De-
tails on those studies are provided below.
Cambridge Baby Growth Study
Between2001and2009,motherswere recruited fromtheRosie
Maternity Hospital, Cambridge, England, by trained research
nurses for participation in the CBGS.10 Ethics approval for the
studywasgivenby theCambridge,England, local researcheth-
ics committee, and written informed consent was obtained
from the mothers. The participants did not receive financial
compensation. At birth, age 1 year, and age 2 years, infant
weightwasmeasured to thenearest 1 gusingelectronic scales,
and supine length was measured to the nearest 0.1 cm (Kid-
dimeter;HoltainLtd). Skinfold thicknessat4sites (triceps, sub-
scapular, flank,andquadriceps)wasmeasuredat thesametime
points in triplicateby trainedresearchnurses (HarpendenSkin-
fold Caliper; Holtain Ltd). Themode of infant feeding (breast
milk only or formula milk) was assessed by a questionnaire
completed by the parents at the 3-month clinic visit, andma-
ternal height was measured to the nearest 0.1 cm.
SouthamptonWomen’s Survey
The SWS is a study ofwomenaged 20 to 34 years recruited via
general practitioners residing inSouthampton,England.11 The
Southampton and South West Hampshire Research Ethics
Committeeapproved the study.Written informedconsentwas
obtained from all participating women and by a parent or
guardian with parental responsibility on behalf of their chil-
dren.At the initial recruitmentvisit,heightwasmeasuredusing
a portable stadiometer (Harpenden; CMS Weighing Equip-
ment Ltd). Infants born to the SWS participants were fol-
lowed-up at ages 6, 12, and 24monthswhen theywere visited
by trained research nurses.12 A detailed history of milk feed-
ing (human milk, baby formulas, and other types of milk)
was obtained at these visits. At age 4 years, the child’s height
(Leicester height measurer; Seca Ltd) and weight in under-
pants only (calibrated digital scales; Seca Ltd) were mea-
sured.Fat and leanmasswereassessedusingwholebodydual-
energy x-ray absorptiometry (DXA) scans (Hologic Discovery
instrument; Hologic Inc) in the pediatric scan mode.13
The EDENMother-Child Cohort Study
EDEN is a population-based, prospective, mother-child co-
hort study on prenatal and early postnatal nutritional, envi-
ronmental, and social determinants of the children’s devel-
opment and health.14 The study was approved by the Ethics
Committee of Kremlin Bicêtre (France) and by the Data Pro-
tectionAuthorityComissionNationalede l’Informatiqueetdes
Libertés. All mothers provided written informed consent for
themselves and their child. Recruitment of pregnant women
expecting singletons tookplacebetween2003 and2006at the
UniversityHospitals inPoitiers andNancy,France.Atbirth, in-
fants were weighed using electronic scales (Seca Ltd), and
length was measured using a wooden somatometer (Testut).
At age 1 year, the infants’ weight was obtained by subtraction
of theweightof themotheralone (TerraillonSL-351) fromwhen
holding their infant wearing light clothes; infant length was
measured using a somatometer (NMMedical). At ages 3 and 5
years, childrenwereweighedwithelectronic scales (SecaLtd),
and standing height was measured with a wall-mounted sta-
diometer (Seca Ltd). At age 5 years, body composition was
evaluated using a body impedance analyzer (BIA 101; Akern).
Breastfeeding duration was assessed from mailed question-
naires at ages 4 and 8 months and at 1, 2, and 3 years. Mater-
nal height was measured to the nearest 0.2 cm.
Barcelona Study
The Barcelona study was designed to assess the longitudinal
associations during the first postnatal years between endo-
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crine-metabolic factorsandbodycomposition.15Thestudywas
approvedby the Institutional ReviewBoardof BarcelonaUni-
versity, Hospital of Sant Joan de Déu; informed written con-
sentwas obtained from at least 1 parent. The Barcelona study
comprises full-term,healthynewbornsbornatHospital of Sant
Joan de Déu, Barcelona, Spain, from 2007 onward, catego-
rized into 2 separate study groups of infants born (1) average
birthweight for gestational age (AGA), whichwas considered
a birth weight range between −1.0 and +1.0 SD, and (2) small
for gestational age (SGA),whichwas consideredabirthweight
range between −2.0 and −3.0 SD. At birth, 1 year, and 2 years,
length (centimeters) was measured in triplicate using a stan-
dardized plastic length board, and weight (grams) was mea-
sured to the nearest 10 g using a standard beambalance (Seca
Ltd). Body composition was assessed by DXA at ages 2 weeks
(range, 9-20 days), 1 year, and 2 years, using a Lunar Prodigy
coupled to specific pediatric Lunar software (version 3.4/3.5;
Lunar Corp) and appropriately adapted by the manufacturer
for measurements in newborns and infants, as described.15
Body Composition
Fat mass and lean mass were estimated by DXA at birth and
age 4 years in SWS, and at birth, age 1 year, and age 2 years in
BarcelonaAGA andBarcelona SGAparticipants. Fatmass and
lean mass were estimated from bioelectric impedance mea-
surements and triceps andsubscapular skinfolds at age 5years
in EDEN, using the equation described by Goran et al,16 and
from skinfoldmeasurements at birth and ages 1 and 2 years in
CBGS, using the equation described by Brook.17 In all studies,
the percentage of fat was calculated as (fat mass × 100/body
weight), and the fat to lean ratio was calculated as (fat mass/
lean mass).
Genotyping
Ineachstudy,DNAwasextracted fromcordbloodsamples col-
lected at birth. Genotypes at 16 single-nucleotide polymor-
phisms (SNPs) weremeasured at theMedical Research Coun-
cilEpidemiologyUnit,Cambridge(iPLEXplatform;Sequenom),
aspreviouslydescribed.18These 16SNPswere reportedashav-
ing genome-wide significant associationswithBMI in adults,9
andalso showedassociationswith childhoodBMIeither in the
previous reports or in additional data (eTable in the Supple-
ment): in or nearNRXN3 (rs10146997), SLC39A8 (rs13107325),
TNNI3K (rs1514175), PTBP2 (rs1555543), MC4R (rs17782313),
FLJ35779 (rs2112347),NEGR1 (rs2568958),RPL27A (rs4929949),
TMEM18 (rs6548238), RBJ/POMC (rs713586), CADM2
(rs7640855), TRA2B/ETV5 (rs7647305), BDNF (rs925946),
TFAP2B (rs987237),FTO (rs9941349), andZNF608 (rs4836133).
Ineachcohortstudy,allvariantspassedgenotypingqualitycon-
trolcriteria(call rate,>95%;Hardy-Weinbergequilibrium,P > .01)
(eTable in the Supplement).
Calculation of Risk-Allele Scores
Combined obesity risk-allele scores, indicating genetic sus-
ceptibility toobesity,were calculated ineachparticipant as the
sumof alleles (range, 0-2 at each locus) associatedwithhigher
adult BMI across the 16 SNP loci. Tominimize dropout due to
missing genotype data, infantswithmissing genotype data at
4 (25%) or fewer loci were imputedwith themean number of
susceptibility alleles in their cohort for each locus.
Statistical Analysis
Body mass index was calculated as weight in kilograms di-
videdby lengthorheight inmeters squaredat each timepoint.
All measures of body size and body composition were con-
verted to sex-specific SDS by comparison with the same Brit-
ish 1990 growth reference.19
The obesity risk-allele score was tested for cross-sectional
associationswithweight, length, BMI, fatmass, leanmass, fat
mass percentage, or fat to lean mass ratio SDS in separate lin-
ear regressionmodels.Eachmodelwasadjusted forageatmea-
surement, sex,maternalheight, andexclusivebreastfeedingat
age3months(yes/no).Modelswereadjustedformaternalheight
rather thanmaternalBMI,because inclusionof the latterwould
likely represent overadjustment for transmitted obesity-
susceptibilityvariants.Althoughmaternal sizeandbreastfeed-
ing cannot confound theassociationbetween infant genesand
infant growth, they contribute to thevariance in infant growth
andwere therefore includedascovariates inouranalyses.Sepa-
ratemodelswereperformedforeachoutcomeateachtimepoint
and ineachcohort study.Theresultingsummarystatistics from
each population-based cohort study and from Barcelona AGA
infants were combined by an inverse weighted fixed-effects
meta-analysis. Toenable this,wegrouped results formeasure-
ment ages between 2 and 3 years andbetween4 and 5years (in
eachagegroup,no individualhad>1growthassessment). βCo-
efficients are used to represent the per-allele effect of the risk-
allele scoreonweight; length/height;BMI; fatmass; leanmass;
percentage of body fat; and fat to lean ratio at birth, 1 year, 2 to
3 years, and 4 to 5 years. Longitudinal analyses were per-
formed only for anthropometry variables (weight, length, and
BMI) owing to thewider variability in timings of body compo-
sitionmeasurements. For thiswe first performedmixed-effect
models separately ineachcohort studyusing thextmixedcom-
mand inStata, version 11.1 (StataCorp), and including the inter-
action term (risk-allele score × age as a continuous variable in
years). The resulting interaction variables were then com-
bined bymeta-analysis as described above; these variables in-
dicate the effects of the risk-allele score on yearly postnatal
changes in weight, length/height, and BMI SDS from birth.
Various sensitivity analyses were performed. To explore
whether there was any potential modifying influence of an-
tenatal environment on the association between the genetic
score and infant growth, we repeated the analyses of risk-
allele score and weight SDS stratified by tertiles of standard-
ized birthweight in each cohort, or by SGAandAGAgroups in
theBarcelona study, and thenmeta-analyzed the resulting sta-
tistics. We also tested for potential effect modification by ex-
clusive breastfeeding at age 3 months (yes/no). All analyses
were conducted in Stata, version 13 (StataCorp).
Results
Descriptive characteristics of the samples included in each co-
hort study are reported in Table 1. All 4 studies had data on
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weight, length/height, and BMI at birth and at ages 1 year and
2 to 3 years; SWS and EDEN also had these data at 4 to 5 years.
Body composition data were available at birth in 3 studies
(CBGS, SWS, and Barcelona), at ages 1 year and 2 to 3 years in
2 studies (CBGSandBarcelona), andatage4 to5years in2 stud-
ies (SWS and EDEN).
Genetic Score AssociationsWithWeight
In our meta-analysis across 4 European population based-
birth cohorts (Figure 1), theobesity risk-allele score showedno
associationwithbirthweight (β = 0.005SDSperallele;P = .53),
but indicated increasingly positive cross-sectional associa-
tions withweight at ages 1 year (β = 0.020; P = .009) and 2 to 3
years (β = 0.033;P < .001). InSWSandEDENcombined, theobe-
sity risk-allele score was associated with weight at 4 to 5 years
(β = 0.040,P < .001) (Table 2). Therewas littleheterogeneity in
effect estimates between the studies (I2 at birth, 33%; at 1 year,
14%; at 2-3 years, 49%; and at 4-5 years, 0%). A meta-analysis
of longitudinal age interaction terms indicated anoverall posi-
tive association between the risk-allele score and change in
weight SDS from birth (β = 0.009 SDS per allele per year;
P < .001).
Genetic Score AssociationsWith Length/Height
In themeta-analysis (Figure 1), theobesity risk-allele scorewas
not associated with birth length (β = 0.006 SDS per allele;
Table 1. Descriptive Characteristics of Children in 4 European Birth Cohort Studies
Characteristic
Mean (SD)a
CBGS
(England)
SWS
(England)
EDEN
(France)
Barcelona (Spain)
AGA SGA
No. of children with
gene scores
618 1229 1352 235 70
Boys, No. (%) 327 (52.9) 643 (52.3) 717 (53.0) 112 (47.6) 31 (44.3)
Genetic score (16 SNPs) 13.8 (2.5) 14.1 (2.5) 13.7 (2.5) 13.8 (2.5) 13.5 (2.5)
Mother’s age at birth, y 33 (4.2) 30.1 (3.7) 29 (4.9) 31 (4.9) 31 (4.8)
Mother’s height, mean, cm 166 (7.0) 163 (7.0) 163 (6.1) 162 (6.3) 159 (5.9)
Mother’s prepregnancy BMI 24.0 (4.1) 25.4 (4.9) 23.1 (4.4) 23.9 (4.2) 23.6 (4.9)
Birth, No. 618 1229 1351 235 70
Weight, kg 3.51 (0.5) 3.45 (0.6) 3.31 (0.48) 3.37 (0.4) 2.32 (0.2)
Length, mean, cm 51.5 (2.6) 49.8 (2.0) 49.7 (2.2) 49.8 (1.7) 45.9 (1.6)
BMI 13.2 (1.6) 13.9 (1.3) 13.4 (1.3) 13.5 (1.2) 13.5 (1.2)
Fat mass, kg 0.61 (0.2) 0.55 (0.2) NA 0.72 (0.3) 0.42 (0.2)
Lean mass, kg 2.9 (0.4) 2.9 (0.4) NA 3.0 (0.4) 2.4 (0.3)
Percentage of fat 17.3 (4.0) 15.1 (4.5) NA 19.2 (6.2) 14.0 (4.9)
1 y, No. 504 1141 1142 148 55
Age, y 1.02 (0.04) 0.99 (0.28) 1.02 (0.08) 1.08 (0.11) 1.06 (0.06)
Weight, kg 10.0 (1.2) 10.1 (1.2) 9.8 (1.12) 10.1 (1.2) 10.1 (1.2)
Length, cm 76.0 (2.8) 75.8 (2.8) 74.9 (2.8) 75.6 (3.4) 75.6 (1.7)
BMI 17.3 (1.4) 17.5 (1.5) 17.5 (1.5) 17.7 (1.7) 16.9 (1.4)
Fat mass, kg 2.9 (0.4) NA NA 3.7 (0.8) 3.4 (0.6)
Lean mass, kg 7.6 (0.9) NA NA 6.5 (1.0) 5.6 (0.9)
Percentage of fat 24.5 (3.3) NA NA 36.0 (6.1) 37.0 (5.3)
2-3 y, No. 458 1058 929 56 46
Age, y 2.03 (0.05) 2.06 (0.14) 3.17 (0.08) 2.10 (0.12) 2.03 (0.06)
Weight, kg 12.6 (1.5) 12.7 (1.5) 14.9 (1.7) 12.5 (1.5) 11.7 (1.3)
Length, cm 87.9 (3.3) 86.6 (3.1) 97.0 (3.8) 87.5 (3.8) 85.4 (3.4)
BMI, kg/m2 16.3 (1.4) 16.9 (1.5) 15.8 (1.1) 16.3 (1.4) 16.0 (1.2)
Fat mass, kg 3.0 (0.6) NA NA 4.6 (1.2) 4.0 (1.2)
Lean mass, kg 9.7 (1.1) NA NA 8.0 (1.2) 7.6 (1.3)
Percentage of fat 23.4 (3.5) NA NA 34.8 (8.4) 32.7 (8.8)
4-5 y, No. NA 538 837 NA NA
Age, y NA 4.13 (0.07) 5.63 (0.16) NA NA
Weight, kg NA 17.5 (2.2) 20.2 (2.7) NA NA
Length, cm NA 103.9 (4.2) 114.4 (4.9) NA NA
BMI NA 16.1 (1.7) 15.4 (1.3) NA NA
Fat mass, kg NA 4.9 (1.2) 2.9 (1.0) NA NA
Lean mass, kg NA 12.0 (1.5) 17.3 (2.1) NA NA
Percentage of fat NA 27.8 (5.0) 14.3 (4.6) NA NA
Abbreviations: AGA, average
gestational age; BMI, bodymass
index (calculated as weight in
kilograms divided by length or height
in meters squared); CBGS; Cambridge
Baby Growth Study; NA, not
available; SGA, small gestational age;
SNPs, single-nucleotide
polymorphisms; SWS, Southampton
Women’s Survey.
a Empty cells indicate that variables
were not measured at the times
reported.
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P = .45), but showed increasingly positive cross-sectional as-
sociations with length at age 1 year (β = 0.020 SDS per allele;
P = .01) and with height at age 2 to 3 years (β = 0.025 SDS per
allele;P < .001). In SWSandEDENcombined, the obesity risk-
allele scorewasassociatedwithheight at4 to5years (β = 0.028
SDS per allele; P = .008) (Table 2). There was little heteroge-
neity between the studies in effect estimates (I2 at birth, 8%;
at 1 year, 34%; at 2-3 years, 45%; and at 4-5 years, 0%). Ameta-
Figure 1. Cross-sectional Associations Between the Obesity Risk-Allele Score and Early Childhood Body Size and Composition
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A, Cross-sectional associations of the obesity risk-allele score with fat and lean
mass sex-adjusted SD scores (SDS) at birth, 12 months, 2-3 years, and 4-5 years.
B, Associations between the obesity-risk allele and weight, length/height, and
bodymass index (BMI) SDS. Ameta-analysis of 4 birth cohorts was conducted.
Data at age 4-5 years are from the EDEN and SouthamptonWomen’s Survey
cohorts only.
a P < .05.
Table 2. Associations Between the Obesity Risk-Allele Score and Body Size FromBirth to Age 4-5 Years in 4 European Birth Cohort Studiesa
Growth Variable by Cohort
Birth
Years
1 2-3 4-5
β (SE) P Value β (SE) P Value β (SE) P Value β (SE) P Value
CBGS, No.b 551 490 450 NA
Weight SDS 0.029 (0.016) .08 0.048 (0.018) .01 0.073 (0.019) <.001 NA NA
Height SDS 0.009 (0.016) .57 0.043 (0.018) .02 0.061 (0.018) .001 NA NA
BMI SDS 0.034 (0.018) .06 0.031 (0.019) .11 0.056 (0.019) .004 NA NA
SWS, No. 1133 1096 1022 518
Weight SDS −0.014 (0.018) .42 0.020 (0.012) .10 0.024 (0.013) .07 0.035 (0.018) .048
Height SDS −0.007 (0.013) .60 0.015 (0.012) .23 0.014 (0.012) .51 0.024 (0.018) .17
BMI SDS −0.007 (0.014) .62 0.019 (0.013) .16 0.018 (0.013) .17 0.028 (0.018) .11
EDEN, No. 1150 1058 873 795
Weight SDS 0.006 (0.01) .50 0.008 (0.011) .50 0.027 (0.011) .02 0.042 (0.013) .001
Height SDS 0.020 (0.012) .09 0.009 (0.012) .43 0.024 (0.012) .043 0.030 (0.013) .02
BMI SDS −0.006 (0.012) .60 0.003 (0.012) .84 0.017 (0.012) .15 0.035 (0.013) .005
Barcelona AGA, No.b 197 123 88 NA
Weight SDS −0.022 (0.024) .36 0.032 (0.039) .37 −0.003 (0.046) .95 NA NA
Height SDS −0.015 (0.022) .51 0.078 (0.042) .07 −0.016 (0.047) .74 NA NA
BMI SDS −0.020 (0.029) .49 −0.022 (0.048) .64 0.004 (0.044) .94 NA NA
Meta-analysis, No. 3031 2767 2433 1313
Weight SDS 0.005 (0.007) .53 0.020 (0.008) .009 0.033 (0.008) <.001 0.040 (0.010) <.001
Length/height SDS 0.006 (0.007) .45 0.020 (0.008) .01 0.025 (0.008) <.001 0.028 (0.010) .008
BMI SDS 0.000 (0.008) .10 0.013 (0.008) .11 0.024 (0.008) .003 0.033 (0.010) .002
Abbreviations: AGA, average gestational age; BMI, bodymass index (calculated
as weight in kilograms divided by length or height in meters squared); CBGS;
Cambridge Baby Growth Study; NA, not available; SDS, sex-adjusted SD scores;
SWS, SouthamptonWomen’s Survey.
a Models were adjusted for age, sex, maternal height, and breastfeeding for
more than 3months. β Indicates regression coefficient (expressed as number
of SDs in the outcome variable per additional BMI-increasing allele).
bVariables were not measured at 4 to 5 years.
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analysis of longitudinal models indicated an overall positive
associationbetween the risk-allele score andchange in length/
height SDS from birth (β = 0.004 SDS per allele per year;
P = .046).
Genetic Score AssociationsWith BMI
In themeta-analysis (Figure 1), theobesity risk-allele scorewas
notassociatedwithBMIatbirth, showedanonsignificantposi-
tive trendwith cross-sectional BMI at age 1 year (β = 0.013 SDS
per risk allele; P = .11), and a positive association with BMI at
age 2 to 3 years (β = 0.024 SDSper risk allele;P = .003). In SWS
and EDEN combined, the obesity risk-allele score was associ-
ated with BMI at 4 to 5 years (β = 0.033 SDS per risk allele;
P = .002) (Table2).Therewas littleheterogeneitybetweenstud-
ies ineffectestimates (I2 atbirth, 34%;at 1year,0%;at2-3years,
14%; and at 4-5 years, 0%). A meta-analysis of longitudinal
models indicated an overall positive association between the
risk-allele score and change in BMI SDS from birth (β = 0.009
SDS per allele per year; P < .001).
Genetic Score AssociationsWith Body Composition
Theobesity risk-allele scorewasnot associatedwith anybody
compositionvariableatbirth in3studies (Figure1). In themeta-
analysis of CBGS and Barcelona combined, the obesity risk-
allele score showed increasingly positive cross-sectional as-
sociationswith both fatmass and leanmass at ages 1 year and
2 to 3 years, and similarly at age 4 to 5 years it was positively
associated with both fat mass (β = 0.028 SDS per allele;
P = .009) and leanmass (β = 0.047SDSper risk allele;P < .001)
in SWS and EDEN combined (Table 3). No associationwas de-
tectedwith thepercentageof fatmass or fatmass to leanmass
ratio at any age. With the exception of estimates for fat mass
at age 2 to 3 years (I2, 79%), there was minimal heterogeneity
betweenstudies ineffectestimates for fatmassor fat-freemass
(all I2 = 0%).
Sensitivity Analysis
Associations with infant growth were similar, albeit slightly
weaker, using aweighted obesity risk-allele score (inwhich in-
Table 3. Associations Between the Obesity Risk-Allele Score and Body Composition FromBirth to Age 4-5 Years in 4 European Birth Cohort Studiesa
Outcome by Cohort
Birth
Age, y
1 2-3 4-5
β (SE) P Value β (SE) P Value β (SE) P Value β (SE) P Value
CBGS, No.b 546 489 441 NA
Fat mass 0.023 (0.015) .13 0.038 (0.018) .04 0.062 (0.019) .001 NA NA
Lean mass 0.016 (0.015) .30 0.041 (0.019) .01 0.064 (0.018) <.001 NA NA
Percentage of fat 0.016 (0.014) .26 0.020 (0.062) .29 0.035 (0.019) .07 NA NA
Fat to lean ratio 0.018 (0.014) .21 0.021 (0.019) .26 0.039 (0.013) .047 NA NA
SWS, No.c 402 NA NA 427
Fat mass 0.013 (0.020) .48 NA NA NA NA 0.019 (0.018) .30
Lean mass −0.016 (0.018) .37 NA NA NA NA 0.051 (0.018) .005
Percentage of fat 0.022 (0.019) .25 NA NA NA NA −0.011 (0.017) .53
Fat to lean ratio 0.021 (0.019) .27 NA NA NA NA −0.008 (0.017) .17
EDEN, No.d NA NA NA 795
Fat mass NA NA NA NA NA NA 0.032 (0.013) .02
Lean mass NA NA NA NA NA NA 0.044 (0.014) .002
Percentage of fat NA NA NA NA NA NA 0.033 (0.014) .02
Fat to lean ratio NA NA NA NA NA NA 0.024 (0.014) .08
Barcelona AGA, No.b 197 123 48 NA
Fat mass −0.007 (0.027) .79 0.005 (0.039) .90 −0.062 (0.054) .26 NA NA
Lean mass −0.003 (0.027) .903 0.026 (0.031) .40 0.063 (0.061) .19 NA NA
Percentage of fat −0.014 (0.027) .61 −0.017 (0.038) .90 −0.076 (0.052) .15 NA NA
Fat to lean ratio −0.010 (0.028) .76 −0.015 (0.037) .69 −0.066 (0.053) .22 NA NA
Meta-analysis, No. 1145 612 489 1222
Fat mass 0.015 (0.011) .17 0.032 (0.017) .05 0.049 (0.018) .006 0.028 (0.011) .009
Lean mass 0.002 (0.011) .86 0.038 (0.014) .008 0.064 (0.017) <.001 0.047 (0.011) <.001
Percentage of fat 0.013 (0.011) .20 0.013 (0.017) .45 0.022 (0.018) .22 0.015 (0.011) .16
Fat to lean ratio 0.015 (0.011) .16 0.014 (0.017) .42 0.027 (0.018) .15 0.011 (0.011) .31
Abbreviations: AGA, average gestational age; CBGS; Cambridge Baby Growth
Study; NA, not available; SWS, SouthamptonWomen’s Survey.
a Models were adjusted for age, sex, maternal height, and breastfeeding for
more than 3months. The regression coefficient β is expressed as the number
of SDs in the outcome variable per additional bodymass index–increasing
allele.
bVariables were not measured at 4-5 years.
c Variables were measured only at birth and 4-5 years.
dVariables were measured only at 4-5 years.
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dividual risk alleleswereweightedby their reportedeffect size
onadultBMI9): theassociationbetweentheweightedrisk-allele
scoreandchangeinweightSDSfrombirthwasβ = 0.006SDSper
alleleperyear (P < .001). In sensitivityanalysesofbodycompo-
sition,withadditional adjustments forbody length/height, the
obesityrisk-allelescoreassociationswithleanmasswereattenu-
atedbut remainedsignificant (4-5years:β = 0.021SDSperallele
per year;P = .03). In analyses stratified bybirthweight groups,
theobesity risk-allele score showedconsistently stronger asso-
ciationswithweight at ages 1 year, 2 to 3 years, and 4 to 5 years
ininfantswhohadaveragebirthweightsthaninthoseinthehigh-
or low-birth-weight groups (Figure 2). Exclusive breastfeeding
atage3months(yes/no)didnotmodifytheassociationsbetween
the obesity risk allele score and infantweight gain (interaction
coefficientforexclusivebreastfeedingvsother:β = 0.005SDSper
allele per year, SE = 0.016, P = .73).
Discussion
Our individual data-level meta-analysis of birth cohort stud-
ies from3European countries confirmed thepositive associa-
tionsbetweengeneticobesitysusceptibilityandpostnatalgains
in infant weight and length, previously reported in an inde-
pendent study,6,7 and showed, for what we believe to be the
first time, positive associations with both fat mass and lean
mass in infancy and early childhood.
Previous studies8,20 have taken a similar approach, using
combined scores of BMI-increasing alleles at adult BMI-
related loci to indicate the genetic susceptibility to obesity.
Some studies8,20 examined only BMI as the outcome growth
variableand identifiedpositiveassociationswithBMI fromage
3yearsandonward.Similarly, apreviousmeta-analysis21of risk
alleles at only theFTO locus across 8 cohorts of individuals of
Europeanancestry reported that theBMI-increasingallelewas
positively associatedwith BMI only from age 5 years onward,
but with no, or even inverse, associations at earlier ages. Our
findings suggest that genetic susceptibility to obesity pro-
motes early gains inbothweight and length/height that are ap-
parent before the positive influence on BMI. This premise is
strongly supported by our novel finding of positive associa-
tions between the obesity risk-allele score and both fat mass
and lean mass, but not relative body fat, in infancy and early
childhood. Notably, these genetic obesity variants are unre-
lated to adult height,7 indicating that their positive associa-
tion with childhood height appears to be fully countered by
earlier pubertal timing and cessation of growth.22
Our findingsmaybe surprising considering that theseobe-
sitysusceptibilityloci, individuallyorincombinations,havebeen
showntohavepredominantpositive associationswithadipos-
ityrather thanleanmass inchildrenaged9years6andinadults.9
Furthermore, gains in length/height and leanmass during in-
fancyandearlychildhoodhavebeensuggested tobeprotective
against, rather thanpredisposing to, obesity and relatedmeta-
bolicdisorders,possiblyowingtothebenefitsofhigherleanmass
and total energy expenditure.23-25 However, in support of our
findings, some largeobservational studies4have reported that
faster postnatal linear growth is associatedwith a higher sub-
sequent riskof childhoodoverweight. Similarly, the long-term
relevance to obesity risk of changes specifically in fat mass or
fat-freemassduring infancy andearly childhoodhasnot been
clearly established. A recent meta-analysis26 showed that
formula-fed comparedwithbreastfed infantshavegreater fat-
freemass in early infancy, but then greater fatmass in later in-
fancy,whichcould indicate thatearlygains in fat-freemasspre-
cedegains in fatmass.Weanticipate that continued follow-up
ofourbirthcohortstudiesmayrevealtheemergenceofpredomi-
nanteffectsof geneticobesity susceptibilityon relativeadipos-
ity, possibly fromnear the ageof the adiposity rebound,which
occurs typically between ages 5 and 7 years.8,21
We found that associations between the obesity risk-
allele score and infancyweightweremore apparent among in-
fants born with average vs high or low birth weight, which is
consistent with a previous report27 comparing genetic influ-
encesonchildhoodBMI inAGA-vsSGA-bornchildren.The lack
of association between genetic susceptibility to obesity and
birth weight has been well described,28 and we suggest that
othermechanisms related tocatch-upandcatch-downgrowth
following intrauterine restriction and overnutrition, respec-
tively,mayhavestronger influencesonpostnatal growth in the
extreme birth-weight groups.
Thereare limitationsofour study.Foremost, accuratemea-
surement of body composition in infants and young children
presentsmajorpractical and technical challenges,not leastow-
ing to the difficulty in achieving immobility and cooperation.
Our studies used a variety of techniques (eg, DXA, skinfolds,
and bioelectric impedance), each of which has limitations in
the assumptionsused to estimatebody composition. Further-
more, the timingofmeasurementsdifferedbetween the stud-
ies, which had not been intentionally designed to allow com-
parison.However, our studies bring together uniquedata sets
onbody composition in early life, and the consistency and ro-
Figure 2. Cross-sectional Associations Between the Obesity Risk-Allele
Score and Early ChildhoodWeight Sex-Adjusted SD Score (SDS)
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bustness of our findings across the studies are reassuring. Fu-
ture use of nonparametric growth modeling techniques may
allow further harmonization of the anthropometric out-
comes across the studies to allowmore-detailed longitudinal
analyses of growth during specific age windows. We did not
havemeasures of body fat distribution; however, separate ge-
netic factors likely contribute to those phenotypes.29 There is
debate regarding the need to adjust body composition fac-
tors in children for differences in length/height, because taller
children tendtohavehigher fat and leanmass.30Althoughonly
associationswith fat-freemass remainedsignificant inour sen-
sitivity analyses adjusted for infant length/height, we con-
tendthat thepositiveassociationsseenacrosspostnatalweight,
length/height, fat mass, and fat-free mass in our main unad-
justed models support a broadly symmetrical effect of ge-
netic obesity susceptibility onearly postnatal growth. This in-
terpretation is consistent with the notions that genetic
susceptibility to obesitymay bemediated to a large extent by
central appetite and satiety regulatorymechanisms that pro-
mote eating behavior and food intake9,31 and that, uniquely
during infancy, nutrition promotes statural growth as well as
weight gain.32 Indeed, there is ample evidence for the nutri-
tional regulationof insulinlikegrowth factor I in infancy,which
likely explains the exquisite sensitivity of statural growth to
energy intake during this early period.10
Our analyses were based on a subset of variants identi-
fied by the latest genome-wide association studies for adult
BMI, inparticular, thosewithdemonstrated associationswith
childhood BMI; the excluded SNPs tended to have lower ef-
fects on adult BMI.9 However, the relevance of effect sizes on
adult BMI for studies of early postnatal body size and growth
isnot clear. Further large replication studies in childrenwould
help to distinguish variantswith predominantly childhoodor
adult effects on weight gain. Finally, although our observed
effect sizes per allele may appear to be small (approximately
0.03-0.06 SDS per allele at age 2-5 years), they are approxi-
mately equivalent to the standardized reportedeffect onadult
BMI (0.17perallele)usingascoreof32SNPs,9andmaybescaled
upward by considering the SD of the obesity risk-allele score
of approximately 2.5 alleles.
Conclusions
Genetic obesity susceptibility appears to promote a normally
partitioned increase in early postnatal, but not prenatal,
growth. Although it is possible that relatively greater gains in
total body and/or regional adiposity might confer additional
risks, our findings suggest that symmetrical rapid growthmay
identify infants with high lifelong obesity susceptibility.
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